首页> 外文期刊>Annals of Surgical Oncology >Clinical Outcomes of Patients with Microsatellite-Unstable Colorectal Carcinomas Depend on L1 Methylation Level
【24h】

Clinical Outcomes of Patients with Microsatellite-Unstable Colorectal Carcinomas Depend on L1 Methylation Level

机译:L1甲基化水平取决于微卫星不稳定结直肠癌患者的临床结果

获取原文
获取原文并翻译 | 示例
           

摘要

Background The prognostic significance of microsatellite instability (MSI) in colorectal cancers (CRCs) has been addressed in many studies since the initial description of better survival rates in MSI-positive (MSI+) tumors than in MSI-negative (MSI−) tumors. Recent studies have demonstrated that a higher degree of hypomethylation of long interspersed nuclear element-1 (L1) is related to poor prognosis of CRCs and that a wide variation of L1 methylation levels exist within MSI+ CRCs. Our aim was to identify whether L1 and Alu methylation status could predict clinical outcomes within MSI+ CRCs.
机译:背景技术自从最初描述了MSI阳性(MSI +)肿瘤的存活率比MSI阴性(MSI-)肿瘤更好的生存率以来,许多研究都已经解决了微卫星不稳定性(MSI)在大肠癌(CRC)中的预后意义。最近的研究表明,较长的散布的核元素1(L1)的甲基化程度较低与CRC的预后不良有关,并且MSI + CRC中存在L1甲基化水平的广泛差异。我们的目的是确定L1和Alu甲基化状态是否可以预测MSI + CRC中的临床结局。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号